Anemia and blood transfusion in the critically ill patient with cardiovascular disease

Critical Care

Volumn 21, Issue 1, 2017, Pages

  Docherty, Annemarie B ^a   Walsh, Timothy S ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; IRON; TROPONIN;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; ANEMIA; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CARDIAC IMAGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL DECISION MAKING; CLINICAL OUTCOME; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DISEASE DURATION; DISEASE ONTOLOGY; ELECTROCARDIOGRAM; ERYTHROCYTE TRANSFUSION; HIGH RISK PATIENT; HUMAN; IRON DEFICIENCY; LENGTH OF STAY; OUTCOME ASSESSMENT; POPULATION RESEARCH; QUALITY OF LIFE; REVIEW; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; COMPLICATION; CRITICAL ILLNESS; TRENDS; UNITED KINGDOM; UTILIZATION;

ANEMIA; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASES; CRITICAL ILLNESS; HUMANS; UNITED KINGDOM;

EID: 85015627325     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-017-1638-9     Document Type: Review

References (53)

1. Ostermann M, Lo J, Toolan M, et al. A prospective study of the impact of serial troponin measurements on the diagnosis of myocardial infarction and hospital and six-month mortality in patients admitted to ICU with non-cardiac diagnoses. Crit Care. 2014;18:R62.
2. British Heart Foundation (2015) Cardiovascular Disease Statistics 2015. https://www.bhf.org.uk/publications/statistics/cvd-stats-2015. Accessed September 2016
3. Walsh TS, McClelland DB, Lee RJ, et al. Prevalence of ischaemic heart disease at admission to intensive care and its influence on red cell transfusion thresholds: multicentre Scottish Study. Br J Anaesth. 2005;94:445-52.
4. Walsh TS, McClelland DB. When should we transfuse critically ill and perioperative patients with known coronary artery disease? Br J Anaesth. 2003;90:719-22.
5. Tune JD, Gorman MW, Feigl EO. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol. 2004;97:404-15.
6. Zeidman A, Fradin Z, Blecher A, Oster HS, Avrahami Y, Mittelman M. Anemia as a risk factor for ischemic heart disease. Isr Med Assoc J. 2004;6:16-8.
7. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111:2042-9.
8. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107:223-5.
9. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-17.
10. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453-62.
11. Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371:1381-91.
12. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11-21.
13. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;372:997-1008.
14. Walsh TS, Boyd JA, Watson D, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med. 2013;41:2354-63.
15. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ. 2015;350:h1354.
16. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;CD002042
17. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med. 2014;127(e123):124-31.
18. Deans KJ, Minneci PC, Suffredini AF, et al. Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols. Crit Care Med. 2007;35:1509-16.
19. Patel NN, Avlonitis VS, Jones HE, et al. Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis. Lancet Haematol. 2015;2:e543-53.
20. Fominskiy E, Putzu A, Monaco F, et al. Liberal transfusion strategy improves survival in perioperative but not in critically ill patients. A meta-analysis of randomised trials. Br J Anaesth. 2015;115:511-9.
21. Docherty AB, O'Donnell R, Brunskill S, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. BMJ. 2016;352:i1351.
22. Bush RL, Pevec WC, Holcroft JW. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. Am J Surg. 1997;174:143-8.
23. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013;165:964-71. e961.
24. Cooper HA, Rao SV, Greenberg MD, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011;108:1108-11.
25. Jairath V, Kahan BC, Gray A, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet. 2015;386:137-44.
26. Parker MJ. Randomised trial of blood transfusion versus a restrictive transfusion policy after hip fracture surgery. Injury. 2013;44:1916-8.
27. de Almeida JP, Vincent JL, Galas FR, et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology. 2015;122:29-38.
28. Gregersen M, Damsgaard EM, Borris LC. Blood transfusion and risk of infection in frail elderly after hip fracture surgery: the TRIFE randomized controlled trial. Eur J Orthop Surg Traumatol. 2015;25:1031-8.
29. National Comparative Audit of Blood Transfusion (2011) Audit of Blood in Adult Medical Patients-Part 1. http://hospital.blood.co.uk/media/26862/nca-medical_use_audit_part_1_report.pdf. Accessed September 2016
30. Wilton K, Fowler RA, Walsh T, Lacroix J, Callum J. Variation of red blood cell transfusion thresholds for critically ill patients. Crit Care. 2014;18:106.
31. Docherty AB, Stanworth SJ, Lone NI, Walsh TS (2016) TROPICCAL: TROPonin I in cardiovascular patients in CriticAL care. https://www.ukctg.nihr.ac.uk. Accessed September 2016
32. Litton E, Baker S, Erber W, et al. The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia. Crit Care Resusc. 2014;16:285-90.
33. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288:2827-35.
34. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551-67.
35. Mehta S, Granton J, Lapinsky SE, et al. Agreement in electrocardiogram interpretation in patients with septic shock. Crit Care Med. 2011;39:2080-6.
36. Lim W, Qushmaq I, Cook DJ, et al. Elevated troponin and myocardial infarction in the intensive care unit: a prospective study. Crit Care. 2005;9:R636-644.
37. Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J. 2011;32:404-11.
38. Retter A, Wyncoll D, Pearse R, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol. 2013;160:445-64.
39. Walsh TS, Saleh EE, Lee RJ, McClelland DB. The prevalence and characteristics of anaemia at discharge home after intensive care. Intensive Care Med. 2006;32:1206-13.
40. Bateman AP, McArdle F, Walsh TS. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med. 2009;37:1906-12.
41. Sabbatini P. The relationship between anemia and quality of life in cancer patients. Oncologist. 2000;5 Suppl 2:19-23.
42. Finkelstein FO, Story K, Firanek C, et al. Health-related quality of life and hemoglobin levels in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4:33-8.
43. Walsh TS, Salisbury LG, Merriweather JL, et al. Increased hospital-based physical rehabilitation and information provision after intensive care unit discharge: The RECOVER randomized clinical trial. JAMA Intern Med. 2015;175:901-10.
44. Lone NI, Gillies MA, Haddow C, et al. Five-year mortality and hospital costs associated with surviving intensive care. Am J Respir Crit Care Med. 2016;194:198-208.
45. Stokes EA, Wordsworth S, Bargo D, et al. Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial. BMJ Open. 2016;6, e011311.
46. Gorcsan 3rd J, Tanaka H. Echocardiographic assessment of myocardial strain. J Am Coll Cardiol. 2011;58:1401-13.
47. De Geer L, Engvall J, Oscarsson A. Strain echocardiography in septic shock - a comparison with systolic and diastolic function parameters, cardiac biomarkers and outcome. Crit Care. 2015;19:122.
48. Cinotti R, Piriou N, Launey Y, et al. Speckle tracking analysis allows sensitive detection of stress cardiomyopathy in severe aneurysmal subarachnoid hemorrhage patients. Intensive Care Med. 2016;42:173-82.
49. Friedrich MG. Tissue characterization of acute myocardial infarction and myocarditis by cardiac magnetic resonance. JACC Cardiovasc Imaging. 2008;1:652-62.
50. Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol. 2008;52:501-11.
51. National Institute for Health and Clinical Excellence (2015) Transfusion. http://www.nice.org.uk/guidance/ng24/evidence/full-guidance-2177160733. Accessed November 2016
52. Klein AA, Arnold P, Bingham RM, et al. AAGBI Guidelines: the use of blood components and their alternatives 2016. Anaesthesia. 2016;71:829-42.
53. Carson JL, Guyatt G, Heddle NM, et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016;316:2025-35.